Qardio receives two CES Innovation Awards for QardioCore wearable ECG monitor

Qardio, Inc., the award-winning maker of smart health solutions for the heart, today announced that it has received two CES Innovation Awards for the upcoming CES 2015 for its QardioCore wearable ECG monitor. QardioCore was honored in two categories:

  • Wearable Technologies
  • Fitness, Sports and Biotech

QardioCore is a wearable ECG monitor offering groundbreaking innovation in heart monitoring. With QardioCore biometric data is collected and transmitted wirelessly to a smartphone or tablet, then pushed automatically to the Qardio Cloud where it is made available to physicians and patients. Built on groundbreaking sensor technology, QardioCore offers unparalleled ease of use and comfort that works around everyday life.

Products entered in this prestigious program are judged by a preeminent panel of independent industrial designers, independent engineers and members of the trade media to honor outstanding design and engineering in cutting edge consumer electronics products.

"We are thrilled by the response our products are receiving from both consumers and medical professionals. Qardio's products are the result of our relentless drive to craft and combine exceptional designs and breakthrough technologies. Today, we are as proud of the two CES Innovation Awards recognizing our work as we are excited by Qardio's upcoming product pipeline to revolutionize heart health," said Marco Peluso, Qardio's CEO.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
America slashes heart attack deaths but faces surge in deadly heart failure and arrhythmias